15-98649578-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_000875.5(IGF1R):c.-4A>G variant causes a 5 prime UTR change. The variant allele was found at a frequency of 0.00000468 in 1,496,984 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000067 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000044 ( 0 hom. )
Consequence
IGF1R
NM_000875.5 5_prime_UTR
NM_000875.5 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 5.35
Genes affected
IGF1R (HGNC:5465): (insulin like growth factor 1 receptor) This receptor binds insulin-like growth factor with a high affinity. It has tyrosine kinase activity. The insulin-like growth factor I receptor plays a critical role in transformation events. Cleavage of the precursor generates alpha and beta subunits. It is highly overexpressed in most malignant tissues where it functions as an anti-apoptotic agent by enhancing cell survival. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, May 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGF1R | NM_000875.5 | c.-4A>G | 5_prime_UTR_variant | 1/21 | ENST00000650285.1 | NP_000866.1 | ||
IRAIN | NR_126453.2 | n.1210T>C | non_coding_transcript_exon_variant | 1/1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGF1R | ENST00000650285.1 | c.-4A>G | 5_prime_UTR_variant | 1/21 | NM_000875.5 | ENSP00000497069 | P4 | |||
IGF1R | ENST00000649865.1 | c.-4A>G | 5_prime_UTR_variant | 1/21 | ENSP00000496919 | A1 | ||||
IGF1R | ENST00000559925.5 | upstream_gene_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.00000675 AC: 1AN: 148252Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
148252
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000445 AC: 6AN: 1348732Hom.: 0 Cov.: 22 AF XY: 0.00000443 AC XY: 3AN XY: 676624
GnomAD4 exome
AF:
AC:
6
AN:
1348732
Hom.:
Cov.:
22
AF XY:
AC XY:
3
AN XY:
676624
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000675 AC: 1AN: 148252Hom.: 0 Cov.: 32 AF XY: 0.0000139 AC XY: 1AN XY: 72064
GnomAD4 genome
AF:
AC:
1
AN:
148252
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
72064
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 28, 2024 | Variant summary: IGF1R c.-4A>G is located in the untranslated mRNA region upstream of the initiation codon. The variant was absent in 238618 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.-4A>G in individuals affected with Growth Delay Due To Insulin-Like Growth Factor I Resistance and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 1683267). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
IGF1R-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 11, 2024 | The IGF1R c.-4A>G variant is located in the 5' untranslated region. To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at